Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

G6PD (AA 308-320) antibody

Antigen

G6PD

Epitope
Alternatives

AA 308-320

Clonality Polyclonal
Host
Reactivity
Alternatives

Human

Application
Alternatives ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Enzyme Immunoassay (EIA)
1 reference available
Catalog no. ABIN190766
Quantity 100µg  (100µg/200µl)
Price 501.80 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 5 Business Days

Additional Information

Gene ID 2539, 14381 (mouse), 24377 (rat)
Swiss-Prot NP_000393.4
Immunogen Peptide with sequence C-STNSDDVRDEKVK, from the internal region of the protein sequence according to NP_000393.4 , NP_001035810.1.
Cross-Reactivity Human, Mouse (Murine), Rat (Rattus), Dog (Canine)
Format Liquid
Grade Serum-free
Description Official Symbol: G6PD
Specificity This antibody is expected to recognise both reported isoforms (NP_000393.4 and NP_001035810.1). Human, Mouse, Rat, Dog

Application Details

Application Notes Peptide ELISA: antibody detection limit dilution 1:32000. Western blot: Approx 55-60kDa double band observed in Human Testis, Thyroid and Tonsil lysates (calculated MW of 62.5kDa according to NP_000393.4 and 59.3kDa accordiong to NP_001035810.1). Recommended concentration: 0.03-0.1µg/ml. IHC: In paraffin embedded Human Testis shows strong cytoplasm staining in spermatogonia. Recommended concentration, 2-4µg/ml. Enzyme immunoassay: Sandwich-type ELISA with increasing amount of recombinant G6PD captured by a rabbit antibody. Recommended reporter concentration: 5-10ug/ml
Concentration 100µg/200µl
Purification Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Buffer Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Storage Aliquot and store at -20°C. Minimize freezing and thawing.
Restrictions For Research Use only

Publications

Publications Guindo, Fairhurst, Doumbo et al.: "X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria." in: PLoS medicine, Vol. 4, Issue 3, pp. e66, 2007 (PubMed).